Evidence map›Paper›PMID 42244627›Full record

ArticlebioRxiv : the preprint server for biology2026

A new Persister Enrichment Model in

Michael W Shultis, Claire V Mulholland, Jinhua Cui, Mei Chen, Samantha Johnson, Christopher Hiner, Michael Berney

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael W ShultisDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Claire V MulhollandDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Jinhua CuiDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Mei ChenDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Samantha JohnsonDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Christopher HinerDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Michael BerneyDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.

Funding

Medical Scientist Training ProgramT32GM149364 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Myles H. Akabas · 2023 to 2026
$7.5M
Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidasesR01AI139465 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERNEY, MICHAEL · 2019 to 2023
$3.2M
The PDIM paradox of M. tuberculosisR01AI175972 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Michael Berney · 2023 to 2026
$2.0M
NIAID NIH HHS R01 AI139465NIAID NIH HHS R01 AI175972NIAID NIH HHS T32 AI007501NIGMS NIH HHS T32 GM149364
6 · The paper itself

Abstract

Prolonged combination chemotherapy is required to cure Tuberculosis, in part because

Identifiers

PMID42244627
PMCPMC13232130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.